Loading clinical trials...
Loading clinical trials...
Azacytidine and venetoclax combination regimen (AZA/VEN) is the standard of care in frontline acute myeloid leukemia (AML) settings for unfit to intensive chemotherapy patients. AZA/VEN combination re...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospices Civils de Lyon
NCT06197672 · Acute Myeloid Leukemia
NCT06285890 · Acute Myeloid Leukemia
NCT07425782 · Acute Myeloid Leukemia, Consolidation Therapy, and more
NCT05429632 · Adult Acute Myeloid Leukemia
NCT06138587 · Acute Myeloid Leukemia, Leukemia, and more
Centre Hospitalier Pierre Oudot | Groupement hospitalier Nord
Bourgoin
METROPOLE SAVOIE - SITE CHAMBERY, place Lucien Biset,
Chambéry
CHU Clermont-Ferrand Site Estaing
Clermont-Ferrand
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions